Ogasawara Masashi, Nishino Ichizo
Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan.
Medical Genome Center, NCNP, Kodaira, Tokyo, Japan.
J Hum Genet. 2023 Mar;68(3):215-225. doi: 10.1038/s10038-022-01045-w. Epub 2022 Jun 7.
In this review, we focus on congenital myopathies, which are a genetically heterogeneous group of hereditary muscle diseases with slow or minimal progression. They are mainly defined and classified according to pathological features, with the major subtypes being core myopathy (central core disease), nemaline myopathy, myotubular/centronuclear myopathy, and congenital fiber-type disproportion myopathy. Recent advances in molecular genetics, especially next-generation sequencing technology, have rapidly increased the number of known causative genes for congenital myopathies; however, most of the diseases related to the novel causative genes are extremely rare. There remains no cure for congenital myopathies. However, there have been recent promising findings that could inform the development of therapy for several types of congenital myopathies, including myotubular myopathy, which indicates the importance of prompt and correct diagnosis. This review discusses the major causative genes (NEB, ACTA1, ADSSL1, RYR1, SELENON, MTM1, DNM2, and TPM3) for each subtype of congenital myopathies and the relevant latest findings.
在本综述中,我们聚焦于先天性肌病,这是一组具有遗传异质性的遗传性肌肉疾病,进展缓慢或极为轻微。它们主要根据病理特征进行定义和分类,主要亚型包括核心肌病(中央核病)、杆状体肌病、肌管/中心核肌病以及先天性纤维类型不均衡性肌病。分子遗传学的最新进展,尤其是新一代测序技术,迅速增加了已知的先天性肌病致病基因数量;然而,与新致病基因相关的大多数疾病极为罕见。先天性肌病仍然无法治愈。不过,最近有一些有前景的发现,可为几种类型的先天性肌病(包括肌管性肌病)的治疗发展提供依据,这表明及时、正确诊断的重要性。本综述讨论了先天性肌病各亚型的主要致病基因(NEB、ACTA1、ADSSL1、RYR1、SELENON、MTM1、DNM2和TPM3)以及相关的最新发现。